(Q52912696)

English

Haptoglobin promoter polymorphism rs5472 as a prognostic biomarker for peptide vaccine efficacy in castration-resistant prostate cancer patients.

scientific article published in October 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428930%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Haptoglobin promoter polymorphism rs5472 as a prognostic biomarker for peptide vaccine efficacy in castration-resistant prostate cancer patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428930%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference

based on heuristic

inferred from title

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428930%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

author name string

Hiromitsu Araki

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428930%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Xiaoliang Pang

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428930%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Nobukazu Komatsu

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428930%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Mikiko Soejima

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428930%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Nawoe Miyata

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428930%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Mari Takaki

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428930%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Shigeru Muta

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428930%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Tetsuro Sasada

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428930%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Masanori Noguchi

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428930%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Kyogo Itoh

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428930%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Satoru Kuhara

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428930%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Kosuke Tashiro

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428930%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

publication date

1 October 2015

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428930%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428930%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

64

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428930%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428930%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1565-1573

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428930%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

https://scigraph.springernature.com/pub.10.1007/s00262-015-1756-7

0 references

Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1756-7

21 January 2018

Next-generation peptide vaccines for advanced cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1756-7

21 January 2018

Immunologic evaluation of personalized peptide vaccination for patients with advanced malignant glioma.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1756-7

21 January 2018

Phase I trial of a personalized peptide vaccine for patients positive for human leukocyte antigen--A24 with recurrent or progressive glioblastoma multiforme.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1756-7

21 January 2018

Phase II study of personalized peptide vaccination for castration-resistant prostate cancer patients who failed in docetaxel-based chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1756-7

21 January 2018

Analysis of pre-treatment markers predictive of treatment benefit for the therapeutic cancer vaccine MVA-5T4 (TroVax).

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1756-7

21 January 2018

The peripheral-blood transcriptome: new insights into disease and risk assessment

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1756-7

21 January 2018

Assessing the human immune system through blood transcriptomics

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1756-7

21 January 2018

Applications of systems biology in cancer immunotherapy: from target discovery to biomarkers of clinical outcome

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1756-7

21 January 2018

Haptoglobin proved a prognostic biomarker in peripheral blood of patients with personalized peptide vaccinations for advanced castration-resistant prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1756-7

21 January 2018

Haptoglobin polymorphism and the immune response after hepatitis B vaccination.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1756-7

21 January 2018

Optimizing the noise versus bias trade-off for Illumina whole genome expression BeadChips

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1756-7

21 January 2018

Adjusting batch effects in microarray expression data using empirical Bayes methods

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1756-7

21 January 2018

A re-annotation pipeline for Illumina BeadArrays: improving the interpretation of gene expression data

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1756-7

21 January 2018

GeneSetDB: A comprehensive meta-database, statistical and visualisation framework for gene set analysis

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1756-7

21 January 2018

Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: a novel approach for the development of tumor markers

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1756-7

21 January 2018

Multiple marker detection in peripheral blood for NSCLC diagnosis

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1756-7

21 January 2018

Circulating haptoglobin is an independent prognostic factor in the sera of patients with epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1756-7

21 January 2018

The tumor microenvironment shapes lineage, transcriptional, and functional diversity of infiltrating myeloid cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1756-7

21 January 2018

Myeloid-derived suppressor cells in cancer: recent progress and prospects.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1756-7

21 January 2018

Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1756-7

21 January 2018

Haptoglobin and sickle cell polymorphisms and risk of active trachoma in Gambian children

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1756-7

21 January 2018

Haplotype association between haptoglobin (Hp2) and Hp promoter SNP (A-61C) may explain previous controversy of haptoglobin and malaria protection

1 reference

https://api.crossref.org/works/10.1007%2FS00262-015-1756-7

21 January 2018

Identifiers

10.1007/S00262-015-1756-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428930%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26428930%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52912696&oldid=1427299485"